Brief: Gland Pharma Receives Establishment Inspection Report From US FDA For Dundigal Facility
16/01/2025 09:48
Jan 16 (Reuters) - Gland Pharma Ltd GLAD.NS :
* RECEIVED ESTABLISHMENT INSPECTION REPORT FROM US FDA FOR
DUNDIGAL FACILITY
Source text: ID:
Further company coverage: GLAD.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Gland Pharma
See all newsBrief: Gland Pharma Says USFDA Conducted Unannounced Inspection At Co’S Formulation Facility At Dundigal
India Stocks: Indian shares open higher as Fed-hike fears, oil prices ease; financials lead
India Stocks: Indian shares poised to rebound as Fed-hike fears, oil prices ease
Brief: Gland Pharma Approves $21 Million Investment In Gland Pharma Usa
Brief: Fosun Pharma Says Unit Sold Gland Pharma Shares for $294 Mln